Welcome to our dedicated page for Infobird Co. news (Ticker: $IFBD), a resource for investors and traders seeking the latest updates and insights on Infobird Co. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Infobird Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Infobird Co.'s position in the market.
Infobird (NASDAQ: IFBD) announced it has not filed its Form 20-F for the fiscal year ended December 31, 2023, by the May 15, 2024, deadline.
Despite the delay, Infobird expects to finalize the financial statements soon. On May 20, 2024, Nasdaq notified the company of non-compliance with Listing Rule 5250(c)(1).
Infobird has until July 19, 2024, to submit a compliance plan, and if accepted, they have until November 11, 2024, to file the form. The company's shares remain listed, and it intends to submit the plan by the deadline.